Cuenta de resultados
ELEVANCE HEALTH, INC.
ELV
Resumen del rendimiento
Haga clic en cualquier fila de la tabla para añadirla al gráfico
en millones de USD
| Métrica | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY | Dec 31, 2010 2010 FY | Dec 31, 2009 2009 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ingresos
|
199,125.00 | 177,011.00 | 171,340.00 | 156,595.00 | 138,639.00 | 121,867.00 | 104,213.00 | 92,105.00 | 90,039.40 | 84,863.00 | 79,156.50 | 73,874.10 | 71,023.50 | 61,711.70 | 60,710.70 | 58,801.80 | 65,028.10 |
|
Coste de los ingresos
|
148,223.00 | 127,567.00 | 141,623.00 | 129,522.00 | 113,540.00 | 96,998.00 | 83,778.00 | 71,895.00 | 72,236.20 | 66,834.40 | 61,116.90 | 56,854.90 | 56,237.10 | 48,213.60 | 47,647.50 | 44,926.90 | 46,571.10 |
|
Beneficio bruto
|
50,902.00 | 49,444.00 | 29,717.00 | 27,073.00 | 25,099.00 | 24,869.00 | 20,435.00 | 20,210.00 | 17,803.20 | 18,028.60 | 18,039.60 | 17,019.20 | 14,786.40 | 13,498.10 | 13,063.20 | 13,874.90 | 18,457.00 |
|
Gastos operativos
|
20,984.00 | 20,025.00 | 20,087.00 | 17,686.00 | 15,914.00 | 17,450.00 | 13,364.00 | 14,020.00 | 12,649.60 | 12,557.90 | 12,534.80 | 11,748.40 | 9,952.90 | 8,738.30 | 8,435.60 | 8,839.40 | 9,659.10 |
|
Investigación y desarrollo
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Ventas, generales y administrativos
|
20,984.00 | 20,025.00 | 20,087.00 | 17,686.00 | 15,914.00 | 17,450.00 | 13,364.00 | 14,020.00 | 12,649.60 | 12,557.90 | 12,534.80 | 11,748.40 | 9,952.90 | 8,738.30 | 8,435.60 | 8,839.40 | 9,659.10 |
|
Otros gastos operativos
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Resultado de explotación
|
29,918.00 | 29,419.00 | 9,630.00 | 9,387.00 | 9,185.00 | 7,419.00 | 7,071.00 | 6,190.00 | 5,153.60 | 5,470.70 | 5,504.80 | 5,270.80 | 4,833.50 | 4,759.80 | 4,627.60 | 5,035.50 | 8,797.90 |
|
Ingresos no operativos
|
23,208.00 | 21,515.00 | 1,915.00 | 1,618.00 | 1,260.00 | 1,181.00 | 1,086.00 | 1,122.00 | 1,189.80 | 915.30 | 873.80 | 902.70 | 993.30 | 894.30 | 669.70 | 681.70 | 1,394.90 |
|
Ingresos por intereses
|
- | - | - | - | - | - | - | - | - | - | - | 768.90 | - | - | - | - | - |
|
Gastos por intereses
|
- | - | 1,030.00 | 851.00 | 798.00 | 784.00 | 746.00 | 753.00 | 739.00 | 723.00 | 653.00 | 600.70 | 602.70 | 511.80 | 430.30 | 418.90 | 447.40 |
|
Otros ingresos/gastos no operativos
|
- | - | - | - | - | 1,418.00 | 1,561.00 | 744.00 | 2,436.70 | 502.40 | 287.80 | -244.30 | - | - | - | - | - |
|
Resultado antes de impuestos
|
6,710.00 | 7,904.00 | 7,715.00 | 7,769.00 | 7,925.00 | 6,238.00 | 5,985.00 | 5,068.00 | 3,963.80 | 4,555.40 | 4,631.00 | 4,368.10 | 3,840.20 | 3,865.50 | 3,957.90 | 4,353.80 | 7,403.00 |
|
Gasto por impuesto sobre beneficios
|
1,048.00 | 1,924.00 | 1,728.00 | 1,744.00 | 1,821.00 | 1,666.00 | 1,178.00 | 1,318.00 | 121.00 | 2,085.60 | 2,071.00 | 1,798.40 | 1,350.50 | 1,210.00 | 1,311.20 | 1,466.70 | 2,657.10 |
|
Participaciones no dominantes
|
-1.00 | -9.00 | 4.00 | -6.00 | -9.00 | - | - | - | - | - | - | - | - | - | - | - | - |
|
Beneficio neto
|
5,662.00 | 5,980.00 | 5,987.00 | 6,025.00 | 6,104.00 | 4,572.00 | 4,807.00 | 3,750.00 | 3,842.80 | 2,469.80 | 2,560.00 | 2,569.70 | 2,489.70 | 2,655.50 | 2,646.70 | 2,887.10 | 4,745.90 |
Información complementaria
Datos por acción, partidas derivadas y otras – no forman parte de la cuenta de resultados
en millones de USD, salvo que se indique lo contrario
| Métrica | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY | Dec 31, 2010 2010 FY | Dec 31, 2009 2009 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciación y amortización
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
29,918.00 | 29,419.00 | 9,630.00 | 9,387.00 | 9,185.00 | 7,419.00 | 7,071.00 | 6,190.00 | 5,153.60 | 5,470.70 | 5,504.80 | 5,270.80 | 4,833.50 | 4,759.80 | 4,627.60 | 5,035.50 | 8,797.90 |
|
Beneficio por acción (básico)
|
25.28 | 25.81 | 25.38 | 25.10 | 25.04 | 18.23 | 18.81 | 14.53 | 14.70 | 9.39 | 9.73 | 9.31 | 8.34 | 8.26 | 7.35 | 7.03 | 9.96 |
|
BPA diluido
|
25.21 | 25.68 | 25.22 | 24.81 | 24.73 | 17.98 | 18.47 | 14.19 | 14.35 | 9.21 | 9.38 | 8.99 | 8.20 | 8.18 | 7.25 | 6.94 | 9.88 |
|
Promedio ponderado de acciones
|
224.00 | 231.70 | 235.90 | 240.00 | 243.80 | 250.80 | 255.50 | 258.10 | 261.50 | 262.90 | 263.00 | 275.90 | 298.50 | 321.50 | 360.20 | 410.90 | - |
|
Promedio ponderado diluido de acciones
|
224.60 | 232.90 | 237.40 | 242.80 | 246.80 | 254.30 | 260.30 | 264.20 | 267.80 | 268.10 | 272.90 | 285.90 | 303.80 | 324.80 | 365.10 | 415.80 | - |
|
Resultado global
|
6,358.00 | 6,146.00 | 7,164.00 | 3,700.00 | 5,776.00 | 5,018.00 | 5,497.00 | 3,276.00 | 4,009.20 | 2,494.50 | 2,095.50 | 2,558.40 | 2,373.80 | 2,839.70 | 2,537.00 | 3,043.60 | 5,798.60 |